ECCO 2019 European Cancer Summit
|Date & Time||September 12-14, 2019|
|Address||Rue Auguste Orts 3-7, 1000
|Location||Brussels Marriott Hotel Grand Place|
The ECCO 2019 European Cancer Summit on 12-14 September 2019 in Brussels, Belgium will bring together worldwide leaders from cancer care, research, patient advocacy and public-private sectors in a unique multi-stakeholder forum. The theme of the second edition of the ECCO Summit is: “European Cancer Care: Across Borders”.
Reaching the 70:35 Vision for cancer – 70% long term survival for all cancer patients across Europe by 2035 – requires breaking down the borders of cancer care: between countries, professions, sectors and stakeholders.
The ECCO 2019 European Cancer Summit will:
- Debate leading-edge ideas in achieving improvement in cancer care;
- Determine consensus resolutions for improving health care systems;
- Decide on an action plan for the way forward to ensure ideas translate into policies that will impact daily clinical practice.
Summit preview: Delivering Mission-orientated Cancer Activity
Professor Mark Lawler of Queen’s University Belfast (QUB) and the Lancet Oncology Groundshot Commission Lead describes some of the major themes the Mission session at the ECCO 2019 European Cancer Summit will address –
“It is encouraging that the next European Commission mandate 2019-24 will see the creation of a unifying EU ‘Cancer Mission’. However, while the details of that mission remain to be seen, it is opportune to gather stakeholders to debate in the open the key issues that surround any major uptake of goal orientated activity in cancer.
- What will success look like?
- What are the pitfalls that we can learn from?
- What are the targets and cohorts that risk being overlooked?
- How do we involve all partners to ensure success?
These and other questions will be opened up and debated in the Cancer Mission session at the ECCO 2019 European Cancer Summit. Contributions to the discussion will be made by leading ECCO members such as the Organisation of European Cancer Institutes (OECI), who have recently been convening pan-European multi-stakeholder meetings on this subject. Also joining the session will be the European Society for Paediatric Oncology (SIOP Europe), who recently published a manifesto of actions that could be taken towards a potential eventual future of zero deaths and zero late effects in paediatric cancer care.”